The new EU GMP Annex 1 draft, Rev 12 specifies the requirements of a pharmaceutical risk assessment to set appropriate microbiological monitoring conditions. This podcast discusses the requirements to use a risk assessment and then provides an interpretation of how to apply and use it in different stages of the manufacturing process.